Clinical Trial Update: Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets [Phase 2]

View source ↗

Summary

Phase 2 trial update on combining dabrafenib and trametinib with radiosurgery for BRAFV600E melanoma brain metastases; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brafv600e Melanoma
• Melanoma Brain Metastases

Drugs mentioned

• Dabrafenib (Dabrafenib)
• Trametinib (trametinib)

Snippet

Sponsor: University of California, San Francisco | Conditions: BRAFV600E Melanoma Patients | Phase 2 | Status: TERMINATED | Results posted: 2018-01-23